Fatigue in pediatric patients with familial Mediterranean fever

References

• Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227–53.
   PubMed Web of Science ®Google Scholar
• Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet. 1998;351:659–64.
   PubMed Web of Science ®Google Scholar
• Majeed HA, Rawashdeh M, el-Shanti H, Qubain H, Khuri-Bulos N, Shahin HM. Familial Mediterranean fever in children: the expanded clinical profile. QJM. 1999;92:309–18.
   PubMed Web of Science ®Google Scholar
• Livneh A, Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol. 2000;14:477–98.
   PubMed Web of Science ®Google Scholar
• The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797–807.
   PubMed Web of Science ®Google Scholar
• French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25–31.
   PubMed Web of Science ®Google Scholar
• Chae JJ, Wood G, Richard K, Jaffe H, Colburn NT, Masters SL, et al. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappa β through its N-terminal fragment. Blood. 2008;112:1794–803.
   PubMed Web of Science ®Google Scholar
• Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1 beta production. Proc Natl Acad Sci USA. 2006;103:9982–7.
   PubMed Web of Science ®Google Scholar
• Ozturk C, Halicioglu O, Coker I, Gulez N, Sutçuoglu S, Karaca N, et al. Association of clinical and genetical features in FMF with focus on MEFV strip assay sensitivity in 452 children from western Anatolia, Turkey. Clin Rheumatol. 2012;31:493–501.
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Sengül B, Yavuzşen TU, Booth DR, Booth SE, Bybee A, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;245:746–50.
   PubMed Web of Science ®Google Scholar
• Ozçakar ZB, Yalçinkaya F, Yüksel S, Acar B, Gökmen D, Ekim M. Possible effect off subclinical inflammation on daily life in familial Mediterranean fever. Clin Rheumatol. 2006;25:149–52.
   PubMed Web of Science ®Google Scholar
• David A, Pelosi A, McDonald E, Stephens D, Ledger D, Rathbone R, et al. Tired, weak, or in need of rest: fatigue among general practice attenders. BMJ. 1990;301:1199–202.
   PubMed Web of Science ®Google Scholar
• Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic Fatigue syndrome. J Psychosom Res 1994;38:383–92.
   PubMed Web of Science ®Google Scholar
• Vercoulen JH, Alberts M, Bleijenberg G. The checklist individidual strength. Gedragstherapie 1999;32:131–6.
   Google Scholar
• Peres MF, Zukerman E, Young WB, Silberstein SD. Fatigue in chronic migraine patients. Cephalalgia. 2002;22:720–4.
   PubMed Web of Science ®Google Scholar
• Repping-Wuts H, Fransen J, van Achterberg T, Bleijenberg G, van Riel P. Persistent severe fatigue in patients with rheumatoid arthritis. J Clin Nurs. 2007;16:377–83.
   PubMed Web of Science ®Google Scholar
• Schmeding A, Schneider M. Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2013;27:363–75.
   PubMed Web of Science ®Google Scholar
• Butbul Aviel Y, Stremler R, Benseler SM, Cameron B, Laxer RM, Ota S, et al. Sleep and fatigue and the relationship to pain, disease activity and quality of life in juvenile idiopathic arthritis and juvenile dermatomyositis. Rheumatology (Oxford). 2011;50:2051–60.
   PubMed Web of Science ®Google Scholar
• Nijhof LN, van de Putte EM, Wulffraat NM, Nijhof SL. Prevalence of severe fatigue among adolescents with pediatric rheumatic diseases. Arhritis Care Res (Hoboken). 2016;68:108–14.
   PubMed Web of Science ®Google Scholar
• Yalçinkaya F, Ozen S, Ozçakar ZB, Aktay N, Cakar N, Düzova A, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology. 2009;48:395–8.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis. 2008;67:1360–4.
   PubMed Web of Science ®Google Scholar
• Ringold S, Ward TM, Wallace CA. Disease activity and fatigue in juvenile idiopathic arthritis. Arthritis Care Res. 2013;65:391–7.
   Web of Science ®Google Scholar
• Varni JW, Burwinkle TM, Szer IS. The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology: reliability and validity. J Rheumatol. 2004;31:2494–500.
   PubMed Web of Science ®Google Scholar
• Fuchs CE, van Geelen SM, van Geel R, Sinnema G, van de Putte EM, Hermans HJ, et al. Health and identity: Self-positioning in adolescent chronic fatigue syndrome and juvenile idiopathic arthritis. Clin Child Psychol Psychiatry. 2013;18:383–97.
   PubMed Web of Science ®Google Scholar
• Ward TM, Archbold K, Lentz M, Ringold S, Wallace CA, Landis CA. Sleep disturbance, daytime sleepiness, and neurocognitive performance in children with juvenile idiopathic arthritis. Sleep. 2010;33:252–9.
   PubMed Web of Science ®Google Scholar
• Norheim KB, Jonsson G, Omdal R. Biological mechanisms of chronic fatigue. Rheumatology (Oxford). 2011;50:1009–18.
   PubMed Web of Science ®Google Scholar
• Yadlapati S, Efthimiou P. Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes. Mod Rheumatol. 2016;26:3–8.
   PubMed Web of Science ®Google Scholar
• Kone-Paut I, Lachmann HJ, Kuemmerle-Deschner JB, Hachulla E, Leslie KS, Mouy R, et al. Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study. Arthritis Res Ther. 2011;13:R202.
   PubMed Web of Science ®Google Scholar
• Marsaud C, Marie I, Kone-Paut I. Longterm followup of quality of life with cryopyrin-associated periodic syndrome treated with canakinumab, an anti-interleukin IL-1β monoclonal antibody. J Rheumatol. 2014;41:1721–2.
   PubMed Web of Science ®Google Scholar
• Ozçakar ZB, Elhan AH, Yalcınkaya F. Can colchicine response be predicted in familial Mediterranean fever patients? Rheumatology (Oxford). 2014;53:1767–72.
   PubMed Web of Science ®Google Scholar